SA pharma expands global presence Aspen Pharmacare, Africa's largest pharmaceutical company, has acquired four pharmaceutical products from GlaxoSmithKline (GSK) for 170-million (approximately R2.7-billion), in a deal with substantially expands the company's international...
Glaxo Deal Opens Way for Aspen to Grow (Business Day/All Africa Global Media via COMTEX News Network) -- Africa's biggest generic drug maker, Aspen Pharmacare, has clinched a licensing and distribution deal with pharmaceutical giant GlaxoSmithKline that will see its products...
APN: APN - Aspen - Aspen businesses in licensing deal with GSK APN - Aspen - Aspen businesses in licensing deal with GSK Aspen Pharmacare Holdings Limited (Incorporated in the Republic of South Africa) (Registration Number 1985/002935/06) (Share code APN & ISIN: ZAE000066692) ('Aspen') ASPEN...
42nd International Childrens Games @ Kezar Stadium Topic - Topic - Loan Online Cigarettes Medical tests Top casino Free Ringtones Medicine news Building materials Cases Intimate goods Bracelets Cheap drugs online shop Ear rings Suits Cars Rolex Replica Cheap pharmacy shop ables Autos...
GSK divests drugs to simplify manufacturing GET THE LATEST MARKET REPORTS All market reports 08-Jul-2008 - GlaxoSmithKline (GSK) has sold four of its off-patent drug products to a South African drugmaker for 170m ($336m), describing the move as part of an ongoing effort to simplify...
GSK divests drugs to simplify manufacturing operations GET THE LATEST MARKET REPORTS All market reports 08-Jul-2008 - GlaxoSmithKline (GSK) has sold four of its off-patent drug products to a South African drugmaker for 170m ($336m), describing the move as part of an ongoing effort to simplify...
GSK Sells Four Drugs to Simplify Manufacturing GlaxoSmithKline (GSK) has sold the intellectual property (IP) rights to four branded drugs for roughly $339 million to Aspen Global.The deal is part of its effort to simplify manufacturing operations by divesting products that can be...
GSK, Aspen enter product divestment agreement GlaxoSmithKline has agreed to sell four products, Eltroxin, Lanoxin, Imuran and Zyloric, to a subsidiary of the South Africa-based pharmaceuticals group, Aspen Global for a cash consideration of $339 million.Aspen will own these...
Aspen Pays R2,7 Billion for Offpatent Glaxo Drugs (Business Day/All Africa Global Media via COMTEX News Network) -- SA's biggest generic drug manufacturer, Aspen Pharmacare Holdings, said yesterday it has bought four of GlaxoSmithKline's older, offpatent drugs for R2,7bn.The deal would...
Aspen Pays R2,7 Billion for Offpatent Glaxo Drugs (Business Day/All Africa Global Media via COMTEX News Network) -- SA's biggest generic drug manufacturer, Aspen Pharmacare Holdings, said yesterday it has bought four of GlaxoSmithKline's older, offpatent drugs for R2,7bn.The deal would...
South Africa: Aspen Pays R2,7 Billion for Offpatent Glaxo Drugs SA's biggest generic drug manufacturer, Aspen Pharmacare Holdings, said yesterday it has bought four of GlaxoSmithKline's older, offpatent drugs for R2,7bn.The deal would give Aspen (APN) a springboard to launch its products into the more...
Aspen pays R2,7bn for offpatent Glaxo drugs CAPE TOWN SAs biggest generic drug manufacturer, Aspen Pharmacare Holdings, said yesterday it has bought four of GlaxoSmithKlines older, offpatent drugs for R2,7bn.The deal would give Aspen (APN) a springboard to launch its products into...
Aspen pays R2,7bn for offpatent Glaxo drugs The deal would give Aspen a springboard to launch its products into the more than 200 markets where Glaxo already sold these drugs.SA's biggest generic drug manufacturer, Aspen Pharmacare Holdings, said on Monday that it has bought four...
GSK's Cervarix faces further delay in USA, deal signed with Aspen The chances of GlaxoSmithKlines Cervarix reaching the US market anytime soon have disappeared after the company said that it will be the end of 2009 at the earliest before the cervical cancer vaccine gets approved across the Atlantic.In a...
GlaxoSmithKline Sells 4 Products To Aspen Global For GBP170 Million Edited Press Release LONDON GSK will record the gain on this transaction in the quarter ended 30 June 2008 GSK's Chief Executive Andrew Witty 'Aspen is a well respected and fast growing pharmaceuticals group with an extensive branded generic...
GlaxoSmithKline to sell to sell 4 products to Aspen, FY EPS guidance unchanged LONDON (Thomson Financial) - GlaxoSmithKline Plc has announced it will sell four products to South African Aspen for 170 million pounds.Europe's biggest drugmaker has agreed to sell the non-US and non-Japan rights of Eltroxin, a thyroid...
Glaxo sells 4 drugs to Aspen for 170m pounds Aspen will own the four drugs in all major markets outside of the United States.LONDON (Reuters) - GlaxoSmithKline Plc has sold four of its older drugs to a unit of South Africa's Aspen Pharmacare Holdings for 170 million pounds, the...
Aspen in deal over brands Aspen Pharmacare Holdings (APN) announced the conclusion of a deal by its wholly-owned subsidiary, Aspen Global Incorporated (Global), with GlaxoSmithKline (GSK), whereby Global has purchased the intellectual property rights to four post...
GlaxoSmithKline Sells 4 Products To Aspen Global For... (DJ) LONDON -(Dow Jones)- GlaxoSmithKline Monday said it had agreed to sell four products, Eltroxin, Lanoxin, Imuran and Zyloric to a subsidiary of the South African based pharmaceuticals group, Aspen Global Incorporated for GBP170 million...
Glaxo sells 4 drugs to Aspen for 170 mln pounds LONDON (Reuters) - GlaxoSmithKline Plc sold four of its older drugs to a unit of South Africa's Aspen Pharmacare Holdings for 170 million pounds, the world's second biggest drugmaker said on Monday.Shares in Aspen fell 3.2 percent to 30...
GlaxoSmithKline to sell to sell 4 products to Aspen, FY EPS guidance unchanged LONDON (Thomson Financial) - GlaxoSmithKline Plc has announced it will sell four products to South African Aspen for 170 million pounds.Europe's biggest drugmaker has agreed to sell the non-US and non-Japan rights of Eltroxin, a thyroid...
Glaxo sells 4 drugs to Aspen for 170 mln pounds LONDON (Reuters) - GlaxoSmithKline Plc (GSK.L: Quote, Profile, Research, Stock Buzz) has sold four of its older drugs to a unit of South Africa's Aspen Pharmacare Holdings (APNJ.J: Quote, Profile, Research, Stock Buzz) for 170 million pounds...
Glaxo sells 4 drugs to Aspen for 170 mln pounds LONDON, June 30 (Reuters) - GlaxoSmithKline Plc (GSK.L: Quote, Profile, Research) has sold four of its older drugs to a unit of South Africa's Aspen Pharmacare Holdings (APNJ.J: Quote, Profile, Research) for 170 million pounds ($339 million)...
